A contemporary review of rearranged during transfection-selective inhibitors.

Liu, Angel W; Liang, Connie; Lee, Chung-Shien

Liu, Angel W; Liang, Connie; Lee, Chung-Shien.

Affiliation

Liu AW; College of Pharmacy and Health Sciences, Department of Clinical Health Professions, 4131St John's University, NY, USA.
Liang C; College of Pharmacy and Health Sciences, Department of Clinical Health Professions, 4131St John's University, NY, USA.
Lee CS; College of Pharmacy and Health Sciences, Department of Clinical Health Professions, 4131St John's University, NY, USA.

J Oncol Pharm Pract ; 28(1): 175-184, 2022 Jan.

Article in En | MEDLINE | ID: mdl-34590525

Subject(s)

Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/genetics; Humans; Lung Neoplasms/drug therapy; Lung Neoplasms/genetics; Proto-Oncogene Proteins c-ret/genetics; Transfection

Key words

Selpercatinib; medullary thyroid cancer; non-small cell lung cancer; pralsetinib; rearranged during transfection; thyroid cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Neuroendocrine / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google